Kuppusamy Senthamizhselvan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kuppusamy Senthamizhselvan has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Pazhanivel Mohan
11 shared publications- Pazhanivel Mohan
Department of Medical Gastroenterology, Jawaharlal Institute of postgraduate Medical Education and Research (JIPMER), Puducherry, India
4 shared publications - Ramkumar Govindarajalou
Department of Radio Diagnosis, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
4 shared publications - Bhawana Ashok Badhe
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India
2 shared publications Dharanesh Daneti
Department of Medical Gastroenterology, JIPMER, Puducherry, India
2 shared publicationsRajeswari Murugesan
Department of Biostatistics, All India Institute of Medical Sciences, Mangalagiri 522 503, India
2 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Springer Nature in Cureus
- Vol. 18 (8)
Ampulla of Vater Metastasis From Colon Cancer Presenting As Obstructive Jaundice
A woman in her late 60s presented with obstructive jaundice. She had mucinous adenocarcinoma of the colon six months ago and underwent surgery followed by adjuvant chemotherapy. A computed tomography scan revealed a prominent ampulla with duodenal wall thickening, dilated intrahepatic biliary radicles, bile ducts, and the main pancreatic duct. Duodenoscopy revealed a bulky, friable, and ulcerated ampulla of Vater (AOV) with partial luminal narrowing. The biopsy and immunohistochemistry (IHC) confirmed adenocarcinoma of colonic origin metastasizing to the AOV. She underwent an endoscopic retrograde cholangiogram and biliary drainage, and best supportive care before dying of her illness. Metastatic involvement of AOV is extremely rare. This case reiterates the need to consider AOV metastasis in the differential diagnosis of obstructive jaundice, especially in patients with a history of malignancy. It also underscores the role of IHC to differentiate AOV primary malignancy from metastasis.
- 25 August 2026
- Published by Springer Nature in Cureus
- Vol. 18 (8)
Open AccessAmpulla of Vater Metastasis From Colon Cancer Presenting As Obstructive Jaundice
A woman in her late 60s presented with obstructive jaundice. She had mucinous adenocarcinoma of the colon six months ago and underwent surgery followed by adjuvant chemotherapy. A computed tomography scan revealed a prominent ampulla with duodenal wall thickening, dilated intrahepatic biliary radicles, bile ducts, and the main pancreatic duct. Duodenoscopy revealed a bulky, friable, and ulcerated ampulla of Vater (AOV) with partial luminal narrowing. The biopsy and immunohistochemistry (IHC) confirmed adenocarcinoma of colonic origin metastasizing to the AOV. She underwent an endoscopic retrograde cholangiogram and biliary drainage, and best supportive care before dying of her illness. Metastatic involvement of AOV is extremely rare. This case reiterates the need to consider AOV metastasis in the differential diagnosis of obstructive jaundice, especially in patients with a history of malignancy. It also underscores the role of IHC to differentiate AOV primary malignancy from metastasis.
- 13 March 2026
- Published by Wolters Kluwer Health in Journal of Minimal Access Surgery
Bowel dysfunction after minimally invasive sphincter-preserving surgery for rectal cancer: A prospective study of prevalence, associated factors and quality of life
Introduction: In rectal cancer patients, bowel dysfunction occurs despite undergoing minimally invasive sphincter-preserving surgery (MI-SPS). This study aimed to find the prevalence and factors associated with bowel dysfunction and quality of life (QoL) after MI-SPS for rectal cancer. Patients and Methods: All rectal cancer patients who had robotic or laparoscopic sphincter-preserving surgery, subsequently underwent stoma closure and attended follow-up clinics from June 2022 to December 2024 were enrolled. Their current symptoms and demographic details were collected. They were subjected to anorectal manometry and a colonic transit study. Bowel dysfunction was assessed using a low anterior resection syndrome (LARS) score. The Memorial Sloan Kettering Bowel Function Instrument (MSK-BFI) questionnaire was used to assess QoL. Results: A total of 73 patients were included. The major and minor LARS occurred in 49 (67.1%) and 18 (24.7%) patients, respectively. The following perioperative factors were significantly associated with the occurrence of bowel dysfunction, namely neoadjuvant chemoradiotherapy (NACTRT) ( P = 0.023), type of surgery ( P = 0.001), type of resection ( P = 0.007), level of anastomosis ( P = 0.001), the technique of anastomosis ( P = 0.003), diverting stoma ( P = 0.016), anastomotic complications ( P = 0.009), the distance of tumour from the anal verge ( P = 0.023) and the height of anastomosis from the anal verge ( P = 0.023). There was no significant association between the colonic transit time and LARS ( P = 0.9), whereas a higher LARS score was significantly associated with lower MSK-BFI scores ( r = −0.82, P < 0.001). Conclusion: Bowel dysfunction after MI-SPS is strongly influenced by NACTRT, anastomotic level and perioperative factors. Higher LARS severity significantly impairs QoL.
- 13 March 2026
- Published by Wolters Kluwer Health in Journal of Minimal Access Surgery
Bowel dysfunction after minimally invasive sphincter-preserving surgery for rectal cancer: A prospective study of prevalence, associated factors and quality of life
Introduction: In rectal cancer patients, bowel dysfunction occurs despite undergoing minimally invasive sphincter-preserving surgery (MI-SPS). This study aimed to find the prevalence and factors associated with bowel dysfunction and quality of life (QoL) after MI-SPS for rectal cancer. Patients and Methods: All rectal cancer patients who had robotic or laparoscopic sphincter-preserving surgery, subsequently underwent stoma closure and attended follow-up clinics from June 2022 to December 2024 were enrolled. Their current symptoms and demographic details were collected. They were subjected to anorectal manometry and a colonic transit study. Bowel dysfunction was assessed using a low anterior resection syndrome (LARS) score. The Memorial Sloan Kettering Bowel Function Instrument (MSK-BFI) questionnaire was used to assess QoL. Results: A total of 73 patients were included. The major and minor LARS occurred in 49 (67.1%) and 18 (24.7%) patients, respectively. The following perioperative factors were significantly associated with the occurrence of bowel dysfunction, namely neoadjuvant chemoradiotherapy (NACTRT) ( P = 0.023), type of surgery ( P = 0.001), type of resection ( P = 0.007), level of anastomosis ( P = 0.001), the technique of anastomosis ( P = 0.003), diverting stoma ( P = 0.016), anastomotic complications ( P = 0.009), the distance of tumour from the anal verge ( P = 0.023) and the height of anastomosis from the anal verge ( P = 0.023). There was no significant association between the colonic transit time and LARS ( P = 0.9), whereas a higher LARS score was significantly associated with lower MSK-BFI scores ( r = −0.82, P < 0.001). Conclusion: Bowel dysfunction after MI-SPS is strongly influenced by NACTRT, anastomotic level and perioperative factors. Higher LARS severity significantly impairs QoL.
- 10 November 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (11) , e266612
Multiple intestinal metastases from signet ring cell cancer of the stomach
A man in his early 40s presented with abdominal pain, diarrhoea, abdominal distension and pedal oedema. Imaging revealed multiple levels of stricture of both the small and large bowel with segmental areas of mucosal hyperenhancement, gross ascites, omental thickening and mild thickening of the gastric mucosa. We initially suspected Crohn’s disease. However, the endoscopy showed a gastric ulcer and multiple ulcero-stenotic lesions in the colon. Biopsy and immunohistochemistry revealed signet ring cell cancer of the stomach with metastases to the small intestine and colon. He received the best supportive care and died after 4 weeks.
- 10 November 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (11) , e266612
Multiple intestinal metastases from signet ring cell cancer of the stomach
A man in his early 40s presented with abdominal pain, diarrhoea, abdominal distension and pedal oedema. Imaging revealed multiple levels of stricture of both the small and large bowel with segmental areas of mucosal hyperenhancement, gross ascites, omental thickening and mild thickening of the gastric mucosa. We initially suspected Crohn’s disease. However, the endoscopy showed a gastric ulcer and multiple ulcero-stenotic lesions in the colon. Biopsy and immunohistochemistry revealed signet ring cell cancer of the stomach with metastases to the small intestine and colon. He received the best supportive care and died after 4 weeks.
- Open Access
- 2 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Mucinous Cystic Neoplasm Coexisting With a Pancreatic Pseudocyst
We report the case of a 45-year-old woman who presented with abdominal pain and distension and was initially diagnosed with a pancreatic pseudocyst. She underwent endoscopic ultrasound (EUS)-guided cystogastrostomy. Biochemical analysis of the cyst fluid revealed elevated carcinoembryonic antigen. Due to persistent symptoms and cyst fluid findings suggestive of mucinous pathology, she subsequently underwent distal pancreatectomy with splenectomy. Histopathology revealed a mucinous cystic neoplasm (MCN) coexisting within a pseudocyst. The patient had an uneventful postoperative recovery and is doing well on follow-up.
- 2 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Open AccessMucinous Cystic Neoplasm Coexisting With a Pancreatic Pseudocyst
We report the case of a 45-year-old woman who presented with abdominal pain and distension and was initially diagnosed with a pancreatic pseudocyst. She underwent endoscopic ultrasound (EUS)-guided cystogastrostomy. Biochemical analysis of the cyst fluid revealed elevated carcinoembryonic antigen. Due to persistent symptoms and cyst fluid findings suggestive of mucinous pathology, she subsequently underwent distal pancreatectomy with splenectomy. Histopathology revealed a mucinous cystic neoplasm (MCN) coexisting within a pseudocyst. The patient had an uneventful postoperative recovery and is doing well on follow-up.
- 11 August 2025
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 27 (1) , 60
Is Eosinophilic Colitis a Forerunner of Inflammatory Bowel Disease?
Eosinophilic colitis (EoC) has an increasing association with inflammatory bowel disease (IBD), and there is a paucity of data on the natural history of EoC. Here, we provide a comprehensive overview of EoC and critically evaluate the evidence supporting its potential association with, or evolution into IBD. Experts currently classify EoC as one of the eosinophilic gastrointestinal disorders (EGID) beyond eosinophilic esophagitis (EoE). Transcriptomic analyses have demonstrated a distinct molecular signature for EoC. However, recent studies suggest that a subset of patients with EoC may progress to develop IBD. The key predictive factors include high eosinophilic density on colonic biopsy and poor response or relapse following standard therapy. Emerging evidence suggests that EoC may precede or overlap with IBD. The lack of standardized diagnostic criteria and limited longitudinal data hinder firm conclusions and warrant future prospective multicenter studies. Available current literature suggests that clinicians should be vigilant with persistent or severe symptomatic patients despite standard treatment to evaluate for IBD.
- 11 August 2025
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 27 (1) , 60
Is Eosinophilic Colitis a Forerunner of Inflammatory Bowel Disease?
Eosinophilic colitis (EoC) has an increasing association with inflammatory bowel disease (IBD), and there is a paucity of data on the natural history of EoC. Here, we provide a comprehensive overview of EoC and critically evaluate the evidence supporting its potential association with, or evolution into IBD. Experts currently classify EoC as one of the eosinophilic gastrointestinal disorders (EGID) beyond eosinophilic esophagitis (EoE). Transcriptomic analyses have demonstrated a distinct molecular signature for EoC. However, recent studies suggest that a subset of patients with EoC may progress to develop IBD. The key predictive factors include high eosinophilic density on colonic biopsy and poor response or relapse following standard therapy. Emerging evidence suggests that EoC may precede or overlap with IBD. The lack of standardized diagnostic criteria and limited longitudinal data hinder firm conclusions and warrant future prospective multicenter studies. Available current literature suggests that clinicians should be vigilant with persistent or severe symptomatic patients despite standard treatment to evaluate for IBD.
- 10 April 2025
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 14 (4) , 1-4
Edwardsiella tarda in Hepatobiliary Disease: Unveiling a Rare Pathogen
Edwardsiella tarda is a rare, gram-negative pathogen, often associated with gastrointestinal or soft tissue infections that can cause severe systemic infections, including bacteremia. This case underscores the need for clinical awareness of E. tarda as a potential pathogen in systemic infections.
- 10 April 2025
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 14 (4) , 1-4
Edwardsiella tarda in Hepatobiliary Disease: Unveiling a Rare Pathogen
Edwardsiella tarda is a rare, gram-negative pathogen, often associated with gastrointestinal or soft tissue infections that can cause severe systemic infections, including bacteremia. This case underscores the need for clinical awareness of E. tarda as a potential pathogen in systemic infections.
- 19 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e263475
Pill-induced esophagitis masquerading esophageal tuberculosis
- 19 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e263475
Pill-induced esophagitis masquerading esophageal tuberculosis
- 7 November 2024
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 45 (1) , 102-104
Utility of spleen volume to body mass index ratio in Crohn’s disease—A retrospective cohort study
- 7 November 2024
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 45 (1) , 102-104
Utility of spleen volume to body mass index ratio in Crohn’s disease—A retrospective cohort study
- 14 August 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (8) , e260802
Sclerosing mesenteritis as a cause of porto-mesenteric vascular obstruction
A woman in her 20s presented with haematemesis, post-prandial abdominal pain, weight loss and anaemia. Imaging revealed a non-enhancing mass in the retroperitoneal space along the mesenteric plane, encasing the porto-mesenteric vasculature. Endoscopy showed oesophageal varices. She was diagnosed with sclerosing mesenteritis, causing extrinsic compression of the portal vein and superior mesenteric artery. She underwent endoscopic variceal ligation and received prednisolone and tamoxifen. After 3 months, her post-prandial pain improved, and she did not have further bleeding episodes.
- 14 August 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (8) , e260802
Sclerosing mesenteritis as a cause of porto-mesenteric vascular obstruction
A woman in her 20s presented with haematemesis, post-prandial abdominal pain, weight loss and anaemia. Imaging revealed a non-enhancing mass in the retroperitoneal space along the mesenteric plane, encasing the porto-mesenteric vasculature. Endoscopy showed oesophageal varices. She was diagnosed with sclerosing mesenteritis, causing extrinsic compression of the portal vein and superior mesenteric artery. She underwent endoscopic variceal ligation and received prednisolone and tamoxifen. After 3 months, her post-prandial pain improved, and she did not have further bleeding episodes.